BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 26656603)

  • 1. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
    Futakuchi M; Fukamachi K; Suzui M
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of bone metastasis.
    Mundy GR
    Cancer; 1997 Oct; 80(8 Suppl):1546-56. PubMed ID: 9362421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.
    Canon J; Bryant R; Roudier M; Branstetter DG; Dougall WC
    Breast Cancer Res Treat; 2012 Oct; 135(3):771-80. PubMed ID: 22926264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer.
    Araujo A; Cook LM; Lynch CC; Basanta D
    Cancer Res; 2014 May; 74(9):2391-401. PubMed ID: 24788098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications.
    De Castro J; García R; Garrido P; Isla D; Massuti B; Blanca B; Vázquez J
    Clin Lung Cancer; 2015 Nov; 16(6):431-46. PubMed ID: 26264596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallmarks of Bone Metastasis.
    Johnson RW; Suva LJ
    Calcif Tissue Int; 2018 Feb; 102(2):141-151. PubMed ID: 29138883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis.
    Nakajima K; Kho DH; Yanagawa T; Harazono Y; Hogan V; Chen W; Ali-Fehmi R; Mehra R; Raz A
    Cancer Res; 2016 Mar; 76(6):1391-402. PubMed ID: 26837763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
    Lee JH; Kim B; Jin WJ; Kim JW; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2014 Sep; 91(1):51-60. PubMed ID: 24929117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Metastasis of Breast Cancer.
    Tahara RK; Brewer TM; Theriault RL; Ueno NT
    Adv Exp Med Biol; 2019; 1152():105-129. PubMed ID: 31456182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer.
    Zhang X
    Cancer Commun (Lond); 2019 Nov; 39(1):76. PubMed ID: 31753020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
    Sterling JA; Edwards JR; Martin TJ; Mundy GR
    Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of tumor metastasis to the bone: challenges and opportunities.
    Reddi AH; Roodman D; Freeman C; Mohla S
    J Bone Miner Res; 2003 Feb; 18(2):190-4. PubMed ID: 12568395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Metastasis from Renal Cell Carcinoma.
    Chen SC; Kuo PL
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment.
    Sato S; Futakuchi M; Ogawa K; Asamoto M; Nakao K; Asai K; Shirai T
    Cancer Sci; 2008 Feb; 99(2):316-23. PubMed ID: 18271931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways.
    Zheng Y; Chow SO; Boernert K; Basel D; Mikuscheva A; Kim S; Fong-Yee C; Trivedi T; Buttgereit F; Sutherland RL; Dunstan CR; Zhou H; Seibel MJ
    J Bone Miner Res; 2014 Sep; 29(9):1938-49. PubMed ID: 24676805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of the bone microenvironment in cancer metastases.
    Casimiro S; Guise TA; Chirgwin J
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):71-81. PubMed ID: 19616059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal model for mammary tumor growth in the bone microenvironment.
    Futakuchi M; Singh RK
    Breast Cancer; 2013 Jul; 20(3):195-203. PubMed ID: 23335063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.